<?xml version='1.0' encoding='utf-8'?>
<document id="27146814"><sentence text="No effects of pantoprazole on the pharmacokinetics of rosuvastatin in healthy subjects."><entity charOffset="14-26" id="DDI-PubMed.27146814.s1.e0" text="pantoprazole" /><entity charOffset="54-66" id="DDI-PubMed.27146814.s1.e1" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.27146814.s1.e0" e2="DDI-PubMed.27146814.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27146814.s1.e0" e2="DDI-PubMed.27146814.s1.e1" /></sentence><sentence text="Rosuvastatin disposition is modulated by the expression and activity of several membrane transporters including BCRP (ABCG2)"><entity charOffset="0-12" id="DDI-PubMed.27146814.s2.e0" text="Rosuvastatin" /></sentence><sentence text=" The objective of our study was to investigate the effects of pantoprazole, a previously proposed BCRP inhibitor, on the disposition of rosuvastatin"><entity charOffset="62-74" id="DDI-PubMed.27146814.s3.e0" text="pantoprazole" /><entity charOffset="136-148" id="DDI-PubMed.27146814.s3.e1" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.27146814.s3.e0" e2="DDI-PubMed.27146814.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27146814.s3.e0" e2="DDI-PubMed.27146814.s3.e1" /></sentence><sentence text="" /><sentence text="The impact of pantoprazole (40 mg ID for 2 days) on rosuvastatin pharmacokinetics was evaluated in healthy volunteers (n = 16) who received a single oral dose of rosuvastatin (10 mg) either alone or with pantoprazole"><entity charOffset="14-26" id="DDI-PubMed.27146814.s5.e0" text="pantoprazole" /><entity charOffset="52-64" id="DDI-PubMed.27146814.s5.e1" text="rosuvastatin" /><entity charOffset="162-174" id="DDI-PubMed.27146814.s5.e2" text="rosuvastatin" /><entity charOffset="204-216" id="DDI-PubMed.27146814.s5.e3" text="pantoprazole" /><pair ddi="false" e1="DDI-PubMed.27146814.s5.e0" e2="DDI-PubMed.27146814.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27146814.s5.e0" e2="DDI-PubMed.27146814.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27146814.s5.e0" e2="DDI-PubMed.27146814.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27146814.s5.e0" e2="DDI-PubMed.27146814.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27146814.s5.e1" e2="DDI-PubMed.27146814.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27146814.s5.e1" e2="DDI-PubMed.27146814.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27146814.s5.e1" e2="DDI-PubMed.27146814.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27146814.s5.e2" e2="DDI-PubMed.27146814.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27146814.s5.e2" e2="DDI-PubMed.27146814.s5.e3" /></sentence><sentence text=" Rosuvastatin, N-desmethylrosuvastatin, and rosuvastatin lactone levels were quantified in plasma while rosuvastatin and N-desmethylrosuvastatin excretion were measured in urine"><entity charOffset="1-13" id="DDI-PubMed.27146814.s6.e0" text="Rosuvastatin" /><entity charOffset="15-38" id="DDI-PubMed.27146814.s6.e1" text="N-desmethylrosuvastatin" /><entity charOffset="44-64" id="DDI-PubMed.27146814.s6.e2" text="rosuvastatin lactone" /><entity charOffset="104-116" id="DDI-PubMed.27146814.s6.e3" text="rosuvastatin" /><entity charOffset="121-144" id="DDI-PubMed.27146814.s6.e4" text="N-desmethylrosuvastatin" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e0" e2="DDI-PubMed.27146814.s6.e0" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e0" e2="DDI-PubMed.27146814.s6.e1" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e0" e2="DDI-PubMed.27146814.s6.e2" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e0" e2="DDI-PubMed.27146814.s6.e3" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e0" e2="DDI-PubMed.27146814.s6.e4" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e1" e2="DDI-PubMed.27146814.s6.e1" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e1" e2="DDI-PubMed.27146814.s6.e2" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e1" e2="DDI-PubMed.27146814.s6.e3" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e1" e2="DDI-PubMed.27146814.s6.e4" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e2" e2="DDI-PubMed.27146814.s6.e2" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e2" e2="DDI-PubMed.27146814.s6.e3" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e2" e2="DDI-PubMed.27146814.s6.e4" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e3" e2="DDI-PubMed.27146814.s6.e3" /><pair ddi="false" e1="DDI-PubMed.27146814.s6.e3" e2="DDI-PubMed.27146814.s6.e4" /></sentence><sentence text="" /><sentence text="Ratios and 90 % standard confidence interval of geometric means for C max (1" /><sentence text="03 [0" /><sentence text="91-1" /><sentence text="16]), AUC0-∞ (1" /><sentence text="03 [0" /><sentence text="89-1" /><sentence text="19]) and renal clearance (0" /><sentence text="96 [0" /><sentence text="85-1" /><sentence text="09]) were all within the pre-specified range of 0" /><sentence text="8-1" /><sentence text="25, indicating a lack of drug-drug interaction between pantoprazole and rosuvastatin"><entity charOffset="55-67" id="DDI-PubMed.27146814.s19.e0" text="pantoprazole" /><entity charOffset="72-84" id="DDI-PubMed.27146814.s19.e1" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.27146814.s19.e0" e2="DDI-PubMed.27146814.s19.e0" /><pair ddi="false" e1="DDI-PubMed.27146814.s19.e0" e2="DDI-PubMed.27146814.s19.e1" /></sentence><sentence text="" /><sentence text="Concomitant administration of pantoprazole with rosuvastatin did not affect rosuvastatin plasma concentrations"><entity charOffset="30-42" id="DDI-PubMed.27146814.s21.e0" text="pantoprazole" /><entity charOffset="48-60" id="DDI-PubMed.27146814.s21.e1" text="rosuvastatin" /><entity charOffset="76-88" id="DDI-PubMed.27146814.s21.e2" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.27146814.s21.e0" e2="DDI-PubMed.27146814.s21.e0" /><pair ddi="false" e1="DDI-PubMed.27146814.s21.e0" e2="DDI-PubMed.27146814.s21.e1" /><pair ddi="false" e1="DDI-PubMed.27146814.s21.e0" e2="DDI-PubMed.27146814.s21.e2" /><pair ddi="false" e1="DDI-PubMed.27146814.s21.e1" e2="DDI-PubMed.27146814.s21.e1" /><pair ddi="false" e1="DDI-PubMed.27146814.s21.e1" e2="DDI-PubMed.27146814.s21.e2" /></sentence><sentence text=" The use of pantoprazole as a BCRP inhibitor should be revisited when characterizing BCRP-mediated transport in humans"><entity charOffset="12-24" id="DDI-PubMed.27146814.s22.e0" text="pantoprazole" /></sentence><sentence text="" /></document>